Analysis of Glypican-1 positive EV in circulation distinguishes with absolute specificity and sensitivity healthy subjects and patients with a benign pancreatic disease from patients with early- and late-stage pancreatic cancer [35, 36] and non-pancreatic cancer [37]. This evidence concerns the gene GPC1 and pancreatic neoplasm.